New! You can now keep track of new articles from Cancer Biotherapy and Radiopharmaceuticals on your personalized homepage!
A new type of alpha-particle irradiator allows survival of each cell to be observed individually along with the size and shape of its nucleus and the positions of the hits it receives. This paper discusses methods of data analysis that can utilize these additional data. Using idealizations of the...
ADEPT (antibody-directed enzyme prodrug therapy) is a novel therapeutic approach that targets an enzyme into tumors to convert a relatively nontoxic prodrug into an active cytotoxic agent. This method has a number of advantages, including the reduction of systemic toxicity, but to date it has not...
Auger-electron cascades with their ability to deposit energy in extremely small volumes, typically in the range of cubic nanometers, have served as valuable probes of radiobiologic phenomena. Results from their experimental use form part of the evidence that nuclear DNA is the most radiosensitive...
Biologically targeted radiotherapy optimization requires accurate dose estimation, from macroscopic to cellular/subcellular dimensions. In particular, dose perturbations produced at interfaces between dissimilar media could affect therapy outcome. The magnitude of these perturbations depends on a...